CAPZA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.995600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.840370E-01
Normal-vs-Stage2
3.864200E-01
Normal-vs-Stage3
2.325800E-01
Normal-vs-Stage4
7.992200E-01
Stage1-vs-Stage2
1.500220E-01
Stage1-vs-Stage3
9.327600E-01
Stage1-vs-Stage4
1.808630E-01
Stage2-vs-Stage3
1.969380E-01
Stage2-vs-Stage4
5.687800E-01
Stage3-vs-Stage4
2.102800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.820600E-01
Normal-vs-AfricanAmerican
6.167000E-01
Normal-vs-Asian
3.956200E-01
Caucasian-vs-AfricanAmerican
6.162800E-01
Caucasian-vs-Asian
9.193400E-01
AfricanAmerican-vs-Asian
7.395600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.298600E-01
Normal-vs-Female
4.223600E-01
Male-vs-Female
1.293810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.977000E-01
Normal-vs-Age(41-60Yrs)
5.745000E-01
Normal-vs-Age(61-80Yrs)
2.374000E-01
Normal-vs-Age(81-100Yrs)
1.720810E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.110770E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.174200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.421000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.453890E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.546360E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.976600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.584420E-01
Normal-vs-Daily Drinker
3.800800E-01
Normal-vs-Weekly Drinker
1.890050E-01
Normal-vs-Occasional Drinker
5.344200E-01
Normal-vs-Social Drinker
3.030200E-01
Non Drinker-vs-Daily Drinker
5.100600E-01
Non Drinker-vs-Weekly Drinker
9.633600E-01
Non Drinker-vs-Occasional Drinker
1.126620E-01
Non Drinker-vs-Social Drinker
5.499200E-01
Daily Drinker-vs-Weekly Drinker
5.753000E-01
Daily Drinker-vs-Occasional Drinker
4.495200E-01
Daily Drinker-vs-Social Drinker
9.661200E-01
Weekly Drinker-vs-Occasional Drinker
1.701000E-01
Weekly Drinker-vs-Social Drinker
5.822200E-01
Occasional Drinker-vs-Social Drinker
4.087200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.858800E-01
Normal-vs-Grade 2
6.717600E-01
Normal-vs-Grade 3
7.035800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.337270E-03
Grade 1-vs-Grade 3
7.177100E-03
Grade 1-vs-Grade 4
8.858800E-01
Grade 2-vs-Grade 3
4.586600E-01
Grade 2-vs-Grade 4
6.717600E-01
Grade 3-vs-Grade 4
7.035800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.950630E-01
Normal-vs-NonDiabetic
2.557800E-01
Diabetic-vs-NonDiabetic
4.973200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.519400E-01
Normal-vs-NoPancreatitis
2.411600E-01
Pancreatitis-vs-NoPancreatitis
5.651000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.547200E-01
Normal-vs-N1
3.543800E-01
N0-vs-N1
1.526950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.097600E-01
Normal-vs-TP53-NonMutant
1.450210E-01
TP53-Mutant-vs-TP53-NonMutant
1.62123999999375E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
